- Dinakar Singh’s 13F portfolio value decreased from $100M to $89M this quarter.
- TPG-Axon reduced Allergan & Amaya and dropped Equifax & Transunion.
- The largest three individual stock positions are Allergan plc, McKesson, and Amaya and they add up to ~57% of the portfolio.
Dinakar Singh’s 13F portfolio value decreased around 11%
from $100M to $89M this quarter. The portfolio is very concentrated with recent
13F reports showing just a handful of positions. The top five positions are
Allergan plc, McKesson Corp., Amaya Inc., Tyson Foods, & Aetna Inc. (AET)
and they add up to ~77% of the 13F portfolio.
Below is a summary:
The Stars Group (TSG)
previously Amaya Inc. (AYA): TSG
is the second-largest stake at ~13% of the portfolio. The position was
purchased over the four quarters thru Q1 2016 at prices between $10.50 and $28.
Q4 2016 saw a ~26% reduction at prices between $13 and $17.50 and that was
followed with a ~85% selling last quarter at around the same price-range. This
quarter saw another ~30% selling at prices between $16.50 and $19.50. The stock
is currently at $16.50.
Allergan plc (AGN):
AGN is currently the largest individual stock position at ~30% of the entire
13F assets. The stake was established in Q3 2015 at prices between $279 and
$331. Q2 2016 saw a ~38% increase at prices between $202 and $278 and that was
followed with another ~20% increase the following quarter at prices between
$231 and $260. Q4 2016 saw an about turn: ~85% reduction at prices between $189
and $243. The stock currently trades at $228. There was a ~17% trimming this
quarter.
Below is a spreadsheet that shows the changes to Dinakar
Singh's TPG-Axon US long portfolio holdings as of Q2 2017. For a look at how the
portfolio has progressed, see our previous update:
To learn more about how to profit from a strategy of
following the best hedge fund picks, check out our book Profiting from Hedge Funds: Winning
Strategies for the Little Guy .
No comments :
Post a Comment